1. Review: Challenges of In Vitro CAF Modelling in Liver Cancers
   Alba Herrero et al, 2021, Cancers CrossRef
2. MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2
   Huiguo Shan et al, 2019, Molecular Medicine Reports CrossRef
3. Proteomic Technology “Lens” for Epithelial-Mesenchymal Transition Process Identification in Oncology
   Monica Neagu et al, 2019, Analytical Cellular Pathology CrossRef
4. Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target
   Richard L. Eckert, 2019, Molecular Carcinogenesis CrossRef
5. Activated hepatic stellate cells promote epithelial-to-mesenchymal transition in hepatocellular carcinoma through transglutaminase 2-induced pseudohypoxia
   Hui Ma et al, 2018, Communications Biology CrossRef
6. Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid
   Xian-Yang Qin et al, 2023, Cell Death & Disease CrossRef
7. The Gαh/phospholipase C-δ1 interaction promotes autophagosome degradation by activating the Akt/mTORC1 pathway in metastatic triple-negative breast cancer
   Hui-Yu Lin et al, 2020, Aging CrossRef